The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study

Mateus Paiva Marques Feitosa, Carlos Serrano, Alexandre Abizaid et al.|Diabetology & Metabolic Syndrome|2023

Cited by 25